Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Identification of drug-specific public TCR driving severe cutaneous adverse reactions.

Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, Schutte R, Ostrov DA, Chen CB, Phillips EJ, Mallal SA, Mockenhaupt M, Bellón T, Tassaneeyakul W, White KD, Roujeau JC, Chung WH, Hung SI.

Nat Commun. 2019 Aug 8;10(1):3569. doi: 10.1038/s41467-019-11396-2.

2.

Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect.

Leong SL, Chaiyakunapruk N, Tassaneeyakul W, Arunmanakul P, Nathisuwan S, Lee SWH.

Int J Cardiol. 2019 Apr 1;280:190-197. doi: 10.1016/j.ijcard.2018.12.049. Epub 2018 Dec 19.

PMID:
30594345
3.

HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.

Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH.

Clin Pharmacol Ther. 2019 Feb;105(2):476-485. doi: 10.1002/cpt.1190. Epub 2018 Sep 30.

PMID:
30270535
4.

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population.

Nakkam N, Konyoung P, Kanjanawart S, Saksit N, Kongpan T, Khaeso K, Khunarkornsiri U, Dornsena A, Tassaneeyakul W, Tassaneeyakul W.

Front Genet. 2018 Aug 6;9:277. doi: 10.3389/fgene.2018.00277. eCollection 2018.

5.

New Advances in Drug Hypersensitivity Research and Treatment.

Tsai YG, Chung WH, Abe R, Tassaneeyakul W.

J Immunol Res. 2018 Jun 21;2018:9345078. doi: 10.1155/2018/9345078. eCollection 2018. No abstract available.

6.

The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.

Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Cheung CM, Huang JW, Ji C, Cheng B, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Huang YH, Lu CW, Yang CY, Lin YT, Chi MH, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Fan WL, Hung SI, Chung WH; Asian Severe Cutaneous Adverse Reaction Consortium.

Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9.

PMID:
29569740
7.

Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia.

Khuankaew C, Apaijai N, Sawaddiruk P, Jaiwongkam T, Kerdphoo S, Pongsiriwet S, Tassaneeyakul W, Chattipakorn N, Chattipakorn SC.

Free Radic Res. 2018 Apr;52(4):415-425. doi: 10.1080/10715762.2018.1438608. Epub 2018 Feb 28.

PMID:
29424256
8.

Comparison between the HLA-B58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions.

Saksit N, Nakkam N, Konyoung P, Khunarkornsiri U, Tassaneeyakul W, Chumworathayi P, Kanjanawart S, Sukasem C, Sangviroon A, Pattanacheewapull O, Tassaneeyakul W.

J Immunol Res. 2017;2017:2738784. doi: 10.1155/2017/2738784. Epub 2017 Dec 17.

9.

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population.

Koomdee N, Pratoomwun J, Jantararoungtong T, Theeramoke V, Tassaneeyakul W, Klaewsongkram J, Rerkpattanapipat T, Santon S, Puangpetch A, Intusoma U, Tempark T, Deesudchit T, Satapornpong P, Visudtibhan A, Sukasem C.

Front Pharmacol. 2017 Nov 29;8:879. doi: 10.3389/fphar.2017.00879. eCollection 2017.

10.

Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population.

Chong HY, Lim YH, Prawjaeng J, Tassaneeyakul W, Mohamed Z, Chaiyakunapruk N.

Pharmacogenet Genomics. 2018 Feb;28(2):56-67. doi: 10.1097/FPC.0000000000000319.

PMID:
29176400
11.

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population.

Tempark T, Satapornpong P, Rerknimitr P, Nakkam N, Saksit N, Wattanakrai P, Jantararoungtong T, Koomdee N, Mahakkanukrauh A, Tassaneeyakul W, Suttisai S, Pratoomwun J, Klaewsongkram J, Rerkpattanapipat T, Sukasem C.

Pharmacogenet Genomics. 2017 Dec;27(12):429-437. doi: 10.1097/FPC.0000000000000306.

PMID:
28885988
12.

SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome.

Makarawate P, Chaosuwannakit N, Vannaprasaht S, Sahasthas D, Koo SH, Lee EJD, Tassaneeyakul W, Barajas-Martinez H, Hu D, Sawanyawisuth K.

J Am Heart Assoc. 2017 Jun 5;6(6). pii: e005009. doi: 10.1161/JAHA.116.005009.

13.

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients.

Wattanachai N, Kaewmoongkun S, Pussadhamma B, Makarawate P, Wongvipaporn C, Kiatchoosakun S, Vannaprasaht S, Tassaneeyakul W.

Eur J Clin Pharmacol. 2017 Aug;73(8):973-980. doi: 10.1007/s00228-017-2265-8. Epub 2017 May 26.

14.

Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication

Chunlertlith K, Limpapanasit U, Mairiang P, Vannaprasaht S, Tassaneeyakul W, Sangchan A, Sawadpanich K, Suttichaimongkol T, Pongpit J, Pattarapongsin M.

Asian Pac J Cancer Prev. 2017 Apr 1;18(4):927-932.

15.

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population.

Saksit N, Tassaneeyakul W, Nakkam N, Konyoung P, Khunarkornsiri U, Chumworathayi P, Sukasem C, Suttisai S, Piriyachananusorn N, Tiwong P, Chaiyakunapruk N, Sawanyawisuth K, Rerkpattanapipat T, Tassaneeyakul W.

Pharmacogenet Genomics. 2017 Jul;27(7):255-263. doi: 10.1097/FPC.0000000000000285.

PMID:
28509689
16.

Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers
.

Nakkam N, Tiamkao S, Kanjanawart S, Phunikhom K, Tiamkao S, Vannaprasaht S, Tassaneeyakul W, Tassaneeyakul W.

Int J Clin Pharmacol Ther. 2017 Feb;55(2):177-185. doi: 10.5414/CP202723.

PMID:
27936524
17.

Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.

Chen CB, Hsiao YH, Wu T, Hsih MS, Tassaneeyakul W, Jorns TP, Sukasem C, Hsu CN, Su SC, Chang WC, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Sun PL, Lee HE, Yang CY, Kao PH, Yang CH, Ho HC, Lin JY, Chang YC, Chen MJ, Lu CW, Ng CY, Kuo KL, Lin CY, Yang CS, Chen DP, Chang PY, Wu TL, Lin YJ, Weng YC, Kuo TT, Hung SI, Chung WH; Taiwan Severe Cutaneous Adverse Reaction Consortium.

Neurology. 2017 Jan 3;88(1):78-86. doi: 10.1212/WNL.0000000000003453. Epub 2016 Dec 2.

PMID:
27913699
18.

Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population.

Tassaneeyakul W, Prabmeechai N, Sukasem C, Kongpan T, Konyoung P, Chumworathayi P, Tiamkao S, Khunarkornsiri U, Kulkantrakorn K, Saksit N, Nakkam N, Satapornpong P, Vannaprasaht S, Sangviroon A, Mahasirimongkol S, Wichukchinda N, Rerkpattanapipat T, Tassaneeyakul W.

Pharmacogenet Genomics. 2016 May;26(5):225-34. doi: 10.1097/FPC.0000000000000211.

PMID:
26928377
19.

Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.

Yothaisong S, Namwat N, Yongvanit P, Khuntikeo N, Puapairoj A, Jutabha P, Anzai N, Tassaneeyakul W, Tangsucharit P, Loilome W.

Parasitol Int. 2017 Aug;66(4):471-478. doi: 10.1016/j.parint.2015.11.011. Epub 2015 Nov 30.

PMID:
26657242
20.

The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions.

Nakkam N, Tiamkao S, Kanjanawart S, Tiamkao S, Vannaprasaht S, Tassaneeyakul W, Tassaneeyakul W.

Drug Metab Pharmacokinet. 2015 Aug;30(4):295-304. doi: 10.1016/j.dmpk.2015.05.003. Epub 2015 May 18.

PMID:
26099919
21.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.

Saito Y, Stamp LK, Caudle KE, Hershfield MS, McDonagh EM, Callaghan JT, Tassaneeyakul W, Mushiroda T, Kamatani N, Goldspiel BR, Phillips EJ, Klein TE, Lee MT; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2016 Jan;99(1):36-7. doi: 10.1002/cpt.161. Epub 2015 Jul 16.

22.

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.

Kongpan T, Mahasirimongkol S, Konyoung P, Kanjanawart S, Chumworathayi P, Wichukchinda N, Kidkeukarun R, Preechakul S, Khunarkornsiri U, Bamrungram W, Supharatwattanakun B, Mootsikapun P, Kwangsukstid S, Denjanta S, Vannaprasaht S, Rungapiromnan W, Suwankesawong W, Tassaneeyakul W, Tassaneeyakul W.

Pharmacogenet Genomics. 2015 Aug;25(8):402-11. doi: 10.1097/FPC.0000000000000153.

PMID:
26086150
23.

High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.

Thongchot S, Yongvanit P, Loilome W, Seubwai W, Phunicom K, Tassaneeyakul W, Pairojkul C, Promkotra W, Techasen A, Namwat N.

Asian Pac J Cancer Prev. 2014;15(14):5873-8.

24.

Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.

Sukasem C, Puangpetch A, Medhasi S, Tassaneeyakul W.

Asian Pac J Allergy Immunol. 2014 Jun;32(2):111-23. Review.

25.

PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.

Jongthawin J, Chusorn P, Techasen A, Loilome W, Boonmars T, Thanan R, Puapairoj A, Khuntikeo N, Tassaneeyakul W, Yongvanit P, Namwat N.

Tumour Biol. 2014 Aug;35(8):8051-64. doi: 10.1007/s13277-014-2021-y. Epub 2014 May 18.

PMID:
24839005
26.

Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand.

Makarawate P, Chaosuwannakit N, Vannaprasaht S, Tassaneeyakul W, Sawanyawisuth K.

Singapore Med J. 2014 Apr;55(4):217-20.

27.

Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population.

Saokaew S, Tassaneeyakul W, Maenthaisong R, Chaiyakunapruk N.

PLoS One. 2014 Apr 14;9(4):e94294. doi: 10.1371/journal.pone.0094294. eCollection 2014.

28.

Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation.

Vannaprasaht S, Reungjui S, Supanya D, Sirivongs D, Pongskul C, Avihingsanon Y, Tassaneeyakul W.

Clin Ther. 2013 Nov;35(11):1762-9. doi: 10.1016/j.clinthera.2013.08.019. Epub 2013 Oct 11.

PMID:
24120259
29.

Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W.

JAMA Dermatol. 2013 Sep;149(9):1025-32. doi: 10.1001/jamadermatol.2013.4114. Review.

PMID:
23884208
30.

Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy.

Auvichayapat N, Rotenberg A, Gersner R, Ngodklang S, Tiamkao S, Tassaneeyakul W, Auvichayapat P.

Brain Stimul. 2013 Jul;6(4):696-700. doi: 10.1016/j.brs.2013.01.009. Epub 2013 Feb 9.

PMID:
23415937
31.

Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers.

Kanjanawart S, Gaysonsiri D, Phunikom K, Simasathiansopon S, Tangsucharit P, Vannaprasaht S, Kaewkamson T, Tassaneeyakul W.

Int J Clin Pharmacol Ther. 2013 Mar;51(3):249-54. doi: 10.5414/CP201748.

PMID:
23357835
32.

Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.

Hershfield MS, Callaghan JT, Tassaneeyakul W, Mushiroda T, Thorn CF, Klein TE, Lee MT.

Clin Pharmacol Ther. 2013 Feb;93(2):153-8. doi: 10.1038/clpt.2012.209. Epub 2012 Oct 17.

33.

Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.

Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W.

World J Gastroenterol. 2012 Aug 14;18(30):3955-61. doi: 10.3748/wjg.v18.i30.3955.

34.

Effects of Phyllanthus amarus on the pharmacokinetics of midazolam and cytochrome P450 activities in rats.

Taesotikul T, Nakajima M, Tassaneeyakul W, Yokoi T.

Xenobiotica. 2012 Jul;42(7):641-8. doi: 10.3109/00498254.2012.655703. Epub 2012 Feb 20.

PMID:
22339466
35.

Effect of albumin on human liver microsomal and recombinant CYP1A2 activities: impact on in vitro-in vivo extrapolation of drug clearance.

Wattanachai N, Tassaneeyakul W, Rowland A, Elliot DJ, Bowalgaha K, Knights KM, Miners JO.

Drug Metab Dispos. 2012 May;40(5):982-9. doi: 10.1124/dmd.111.044057. Epub 2012 Feb 13.

PMID:
22331994
36.

Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells.

Loilome W, Juntana S, Pinitsoontorn C, Namwat N, Tassaneeyakul W, Yongvanit P.

Asian Pac J Cancer Prev. 2012;13 Suppl:143-7.

37.

High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma.

Srimunta U, Sawanyawisuth K, Kraiklang R, Pairojkul C, Puapairoj A, Titipungul T, Hahnvajanawong C, Tassaneeyakul W, Wongkham C, Wongkham S, Vaeteewoottacharn K.

Asian Pac J Cancer Prev. 2012;13 Suppl:125-30.

38.

Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers.

Kanjanawart S, Gaysonsiri D, Tangsucharit P, Vannaprasaht S, Phunikhom K, Kaewkamson T, Wattanachai N, Tassaneeyakul W.

Int J Clin Pharmacol Ther. 2011 Aug;49(8):525-30.

PMID:
21781653
39.

Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma.

Yongvanit P, Phanomsri E, Namwat N, Kampan J, Tassaneeyakul W, Loilome W, Puapairoj A, Khuntikeo N.

Parasitol Int. 2012 Mar;61(1):162-6. doi: 10.1016/j.parint.2011.06.026. Epub 2011 Jul 2.

PMID:
21745589
40.

HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.

Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.

PMID:
21676164
41.

In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance.

Wattanachai N, Polasek TM, Heath TM, Uchaipichat V, Tassaneeyakul W, Tassaneeyakul W, Miners JO.

Eur J Clin Pharmacol. 2011 Aug;67(8):815-24. doi: 10.1007/s00228-011-1001-z. Epub 2011 Feb 9.

PMID:
21305272
42.

Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition.

Taesotikul T, Dumrongsakulchai W, Wattanachai N, Navinpipat V, Somanabandhu A, Tassaneeyakul W, Tassaneeyakul W.

Drug Metab Pharmacokinet. 2011;26(2):154-61. Epub 2010 Dec 17.

43.

Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Namwat N, Puetkasichonpasutha J, Loilome W, Yongvanit P, Techasen A, Puapairoj A, Sripa B, Tassaneeyakul W, Khuntikeo N, Wongkham S.

J Gastroenterol. 2011 May;46(5):664-75. doi: 10.1007/s00535-010-0345-y. Epub 2010 Nov 13.

PMID:
21076843
44.

Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin.

Sangviroon A, Panomvana D, Tassaneeyakul W, Namchaisiri J.

Drug Metab Pharmacokinet. 2010;25(6):531-8. Epub 2010 Oct 1.

45.

Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration.

Tassaneeyakul W, Kumar S, Gaysonsiri D, Kaewkamson T, Khuroo A, Tangsucharit P, Phunikhom K, Vannaprasaht S, Kanjanawart S, Rao Thudi N, Jain R, Reyar S, Monif T.

Int J Clin Pharmacol Ther. 2010 Sep;48(9):614-20.

PMID:
20860915
46.

Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines.

Hahnvajanawong C, Boonyanugomol W, Nasomyon T, Loilome W, Namwat N, Anantachoke N, Tassaneeyakul W, Sripa B, Namwat W, Reutrakul V.

World J Gastroenterol. 2010 May 14;16(18):2235-43.

47.

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.

Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P.

Epilepsia. 2010 May;51(5):926-30. doi: 10.1111/j.1528-1167.2010.02533.x. Epub 2010 Mar 19.

48.

Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.

Feng Q, Vannaprasaht S, Peng Y, Angsuthum S, Avihingsanon Y, Yee VC, Tassaneeyakul W, Weinshilboum RM.

Biochem Pharmacol. 2010 Apr 1;79(7):1053-61. doi: 10.1016/j.bcp.2009.11.016. Epub 2009 Nov 27.

49.

The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population.

Apinan R, Tassaneeyakul W, Mahavorasirikul W, Satarug S, Kajanawart S, Vannaprasaht S, Ruenweerayut R, Na-Bangchang K.

Environ Toxicol Pharmacol. 2009 Nov;28(3):420-4. doi: 10.1016/j.etap.2009.07.004. Epub 2009 Jul 14.

PMID:
21784037
50.

Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers.

Tangsucharit P, Kampan J, Kanjanawart S, Gaysonsiri D, Vannaprasaht S, Tiamkao S, Phunikhom K, Simasathiansophon S, Puapairoj P, Tassaneeyakul W.

Int J Clin Pharmacol Ther. 2009 Oct;47(10):638-42.

PMID:
19825327

Supplemental Content

Loading ...
Support Center